Skip to main content

Renal Diseases Drug Development Pipeline Review 2018 – AdAlta , Allena Pharmaceuticals , apceth Biopharma , Arch Biopartners , Astellas Pharma , AstraZeneca , Bayer

This report provides an overview of the pipeline landscape for renal diseases. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for chronic kidney disease (chronic renal failure), kidney fibrosis, polycystic kidney disease and end-stage kidney disease (end-stage renal disease), and features dormant and discontinued products. Chronic kidney disease is the slow loss of kidney function over time. Signs and symptoms of kidney disease include nausea, vomiting, loss of appetite, fatigue and weakness, sleep problems, hiccups and swelling of the feet and ankles. The predisposing factors include age, diabetes, high blood pressure, heart disease, smoking, obesity and high cholesterol. There are 58 products in development for this indication.
Some of Key Players are: 
AdAlta , Allena Pharmaceuticals , apceth Biopharma , Arch Biopartners , Astellas Pharma , AstraZeneca , Bayer , BiOrion Technologies , Boehringer Ingelheim , Boryung Pharmaceutical , Celgene , Certa Therapeutics , Conatus Pharmaceuticals , Corvidia Therapeutics , DiaMedica Therapeutics , Dimerix Bioscience , DiscoveryBiomed , DURECT C, Epigen Biosciences , Galectin Therapeutics , GenKyoTex , GNI Group , iBio Inc, IC-MedTech , Ipsen , Isarna Therapeutics , KBP BioSciences , Kidney Fibrosis, Klotho Therapeutics , Les Laboratoires Servier ,
Accumulation of extracellular matrix in the kidney causes kidney fibrosis. It is a progressive disorder characterized by glomerulosclerosis and tubulointerstitial fibrosis and may lead to detrimental effects on the kidney functioning. Predisposing factors are trauma, injury, infections, surgery, environmental factors and exposure to chemicals or radiation. Symptoms include pain, problems related to urination, nausea and vomiting. The condition may be managed with medication and kidney transplant. There are 49 products in development for this indication.
Polycystic kidney disease is a disorder in which clusters of cysts develop primarily within the kidneys. Polycystic kidney disease symptoms may include high blood pressure, back or side pain, headache, blood in the urine, frequent urination and kidney failure. The predisposing factors include age and family history. Treatment includes antihypertensive drugs and diuretics. There are 26 products in development for this indication.
End-stage kidney disease is the complete or almost complete failure of the kidneys to work. Symptoms include inability to urinate, fatigue, headaches, loss of appetite, nausea and vomiting, bone pain, confusion and difficulty concentrating. The risk factors include polycystic kidney disease, Alport syndrome, interstitial nephritis and certain autoimmune conditions, such as lupus. Treatment includes dialysis or kidney transplant. There are five products in development for this indication.
Molecular targets in development for renal diseases include growth factor receptors, chemokines and kinases. Companies operating in this pipeline space include Angion Biomedica, Prolong Pharmaceuticals and Novartis.
Scope
- Which companies are the most active within each pipeline-
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication-
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies-
- What are the most important R&D milestones and data publications to have happened in this disease area-
 Table of Contents
1 Table of Contents 
1.1 List of Tables
1.2 List of Figures
2 Introduction 
2.1 Renal Diseases Report Coverage
2.2 Chronic Kidney Disease (Chronic Renal Failure) - Overview
2.3 Kidney Fibrosis - Overview
2.4 Polycystic Kidney Disease - Overview
2.5 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Overview
3 Therapeutics Development 
3.1 Chronic Kidney Disease (Chronic Renal Failure)
3.2 Kidney Fibrosis
3.3 Polycystic Kidney Disease
3.4 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
4 Therapeutics Assessment 
4.1 Chronic Kidney Disease (Chronic Renal Failure)
4.2 Kidney Fibrosis
4.3 Polycystic Kidney Disease
4.4 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
5 Companies Involved in Therapeutics Development 
5.1 Chronic Kidney Disease (Chronic Renal Failure)
5.2 Kidney Fibrosis
5.3 Polycystic Kidney Disease
5.4 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
6 Dormant Projects 
6.1 Chronic Kidney Disease (Chronic Renal Failure)
6.2 Kidney Fibrosis
6.3 Polycystic Kidney Disease
6.4 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
7 Discontinued Products 
7.1 Chronic Kidney Disease (Chronic Renal Failure)
7.2 Kidney Fibrosis
7.3 Polycystic Kidney Disease
7.4 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
8 Product Development Milestones 
8.1 Chronic Kidney Disease (Chronic Renal Failure)
8.2 Kidney Fibrosis
8.3 Polycystic Kidney Disease
9 Appendix 
9.1 Methodology
9.2 Coverage
9.3 Secondary Research
9.4 Primary Research
9.5 Expert Panel Validation
9.6 Contact Us
9.7 Disclaimer
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com
Labels:

Comments

Post a Comment

Popular posts from this blog

Crop Breeding Technology Market Future Technological Growth and Demand and Business Opportunities 2024 – BASF , Dupont Pioneer , Syngenta , Advanta

Crop Breeding Technology Market report provides in-depth statistics and analysis available on the market status of the Crop Breeding Technology Manufacturers and is a valuable method of obtaining guidance and direction for companies and business enterprise insider considering the Crop Breeding Technology market. It contains the analysis of drivers, challenges, and restraints impacting the industry. Crop Breeding Technology Market report also provide a thorough understanding of the cutting-edge competitive analysis of the emerging market trends along with the drivers, restraints, challenges, and opportunities in the Crop Breeding Technology Market to offer worthwhile insights and current scenario for making right decision. The report covers the prominent players in the market with detailed SWOT analysis, financial overview, and key developments of the products/services from the past three years. Moreover, the report also offers a 360º outlook of the market through the competitive la
Post a Comment
Read more

Home Entertainment Market Growth 2016-2022 Leading Key Players – Sony Corporation, Apple , Panasonic Corporation, LG Electronics , Samsung, Bose Corporation, Sennheiser Electronic

Global home entertainment market is estimated to reach $294,969 million by 2022. Home entertainment market includes products and systems used in domestic or personal context. The market includes several consumer electronic products such as television sets, video players & recorders, audio equipment, and gaming devices. Over the past few years, there is a significant rise in consumer investments in entertainment products mainly owing to the increase in disposable income and development of innovative entertainment solutions from manufacturers. The global market witnesses substantial growth due to increase in digitization of electronic goods, rapid innovations in existing products, decline in prices, and increase in tech-savvy urban population in developing countries. However, the market growth for these products is mitigated by increase in consumer shift toward mobile platforms and consumer apprehensions due to adverse effects on health from audio equipment and wireless devices.
Post a Comment
Read more

Smart Polymers Market Research Report: Size, Share, Growth, Trends and Forecast 2022

Smart Polymers Market size was valued at $1,250 million in 2015, and is anticipated to grow at a CAGR of 12.6% to reach $3,070 million by 2022. Smart polymers are also referred to as intelligent polymers or environmentally sensitive polymers. The ability to respond to a slight environmental fluctuation is the major feature that makes these polymers smart. These are sensitive to various environmental stimulus such as pH, temperature, magnetic field, electric field, chemical agents, enzymes, and biomolecules and possess the ability to recover at their initial state at the culmination of the stimulus. The market is in its growth stage owing to the recognition by academic and industrial research, whereas, the drivers for market growth are increase in need for efficient & economical drug delivery system, innovative use of smart polymers in automotive industry, and beneficial property of phase transition. However, high cost associated with the use of smart polymers is projected to hamp
Post a Comment
Read more